Patient is the word.1 Feb 2022 12:25
I'm unconvinced of the talents of the managers. I think they opportunistically took over management on a juicy 1% of NAV (no performance fee) when the Trust was in a somewhat distressed state, with the BOD urgently scrabbling around trying to find a successor to Woodford. There were few takers given the Trust's indebtedness and the 'toxicity' (as it was seen) of the Woodford portfolio, so it was an easy 'win' for the Schroder Juniors. The loss on JMAT wasn't huge, but I fear it's indicative. I hated their pompous hubris when announcing that investment. Very poor.
So, future success remains almost entirely dependent on the punts of a manager sacked more than 2 years ago. Can anyone tell me that two of the Trust's biggest holdings outside of ONT, namely Atom Bank and Rutherford Health, have a great future? We've been waiting *years* for them to come good.
I'm sorry to be so negative, but before I'm accused of being a shorter or some such, I should say that I originally bought large at 80p and then topped up aggressively at 40p, with no sells, so am heavily underwater. I have never had and will never have such a big loss in pounds, shillings & pence as with this investment. Ok, I've made it back elsewhere, but it sure took a while.
Why don't I just get out and crystallise my loss? Curiosity (because this is indeed a "special situstion")... plus, a big kick of loss aversion.
Stating the obvious, an investment here is a bet on Woodford's legacy picks coming good. If you want talented specialist managers funding interesting private equities on a continuing basis, look elsewhere. Check OCI, which illustrates the returns available from private equity investing done well. Thank God I also invested in that.